• Genetic variation near IRS-1 results in decreased IRS-1 expression. This is associated with impaired metabolic profile - increased visceral to subcutaneous fat ratio, insulin resistance, hyperlipidaemia, decreased adiponectin levels → enhancing the risk of diabetes and CAD.109,110. Here, ADIPOQ is linked to Insulin resistance.